Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Anyone can

"When did PTSC first know about this Ownership dispute, and how or when will PTSC assure or address the concerns and questions of Shareholders."

As a starting point, we could consider december 2008. End of november....insiders purchased an aggregate total of 1,360,000 shares.

Share
New Message
Please login to post a reply